by EpicentRx | Jul 18, 2023 | Blog
Necessity is the mother of invention, so the saying goes. Sometimes it is also the father. The father in this case is Dr. Tony Reid, previously the Primary Investigator (PI) on the first-in-human (FIH) clinical trial for nibrozetone (RRx-001) (see blog post entitled...
by EpicentRx | Jul 17, 2023 | Blog
“The meek shall inherit…the Words of the Week.” NO Definition: Noun: A colorless gas and a stable free radical that nibrozetone (RRx-001) generates at extremely high levels in hypoxic/reductive environments. Example sentence: “NO laughing matter: NO, which stands for...
by EpicentRx | Jul 14, 2023 | Blog
Ok, so that just happened. Elon Musk challenged Mark Zuckerberg to, ahem, a measuring contest. Well, not to wade headlong (or with another anatomical part) into this debate, but let’s just say, Mr. Musk, that size isn’t everything. Case in point: AdAPT-001. This is an...
by EpicentRx | Jul 12, 2023 | Blog
This summer Barbie—and hot pink Barbiecore—are everywhere. And so is the plastic, recycled or otherwise, that the iconic Barbie dolls, dreamhouses, playsets, games, and pink convertibles are made from and wrapped in. With over a billion dolls sold worldwide and a new...
by EpicentRx | Jul 11, 2023 | Blog
The First Amendment to the U.S. Constitution guarantees the right to freedom of expression. (See blog post entitled, AdAPT-001 and the Bill of Rights.) AdAPT-001, a modified common cold adenovirus, which carries a transforming growth factor-beta (TGF-β) trap,...
